Fidelity Enhanced Small Cap ETF(FESM.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Fidelity Enhanced Small Cap ETF
FESM.US
News
View More

BUZZ-Silver miners gain as metal price breaches $90 per ounce

U.S.-listed silver miners' shares rise as silver prices exceed $90 per ounce, up 3.8% at $90.31. This increase follows softer U.S. inflation data, boosting expectations for interest rate cuts amid geopolitical uncertainty. Silver has surged 27% this year and 146% in 2025. Notable gains include Hecla Mining (+3.3%), Coeur Mining (+3%), and Canadian miners like Wheaton Precious Metals (+1.7%). ETFs such as Abrdn Physical Silver Shares and iShares Silver Trust both rise 3.9%, while ProShares Ultra Silver jumps 7.9%.

Reuters·
US
CDE
+2.22%
US
HL
+5.97%
US
WPM
+1.77%
Reuters·
US
CDE
+2.22%
US
HL
+5.97%
US
WPM
+1.77%

Credo Technology is surging on AI tailwinds. Should investors buy after earnings?

The company's focus on high-speed connectivity solutions is delivering a surge in business.

MSN·
US
CRDO
-4.92%
MSN·
US
CRDO
-4.92%

BUZZ-Silver miners gain as prices reach record high

Shares of silver miners rise premarket, tracking rise in white metal’s prices (GOL/) Spot silver (XAG=) rises 2.3% to record high of $86.90 per ounce Prices supported by concerns over Russia intensifying attacks on Ukraine and unrest in Iran, while investor caution ahead of key inflation data limited upside momentumHecla Miningup 2.2%; Coeur Miningrises 1.3%U.S.-listed shares of Canadian miners: Endeavour Silver (EDR.TO) up 1.5%; Silvercorp Metals (SVM.TO) gains 1.3%Both Abrdn Physical Silver Shares ETF (SIVR.P) and iShares Silver Trust ETF (SLV.P) up 2% each

Reuters·
US
SVM
+1.29%
US
EXK
+3.21%
US
CDE
+2.22%
Reuters·
US
SVM
+1.29%
US
EXK
+3.21%
US
CDE
+2.22%

Credo Technology Group (NASDAQ:CRDO) Trading Up 3.8% - Still a Buy?

Credo Technology Group (NASDAQ:CRDO) shares rose 3.8% to $156.07, with a trading volume of 4.57 million, down 35% from average. Positive sentiment from analysts and retail press highlights CRDO as a momentum pick, while insider selling by executives raises concerns. Analysts maintain a consensus rating of "Buy" with a target price averaging $217.08. The company reported strong earnings, with a 272.1% year-over-year revenue increase. Despite insider sales, the overall outlook remains positive with several upgrades from brokerages.

Market Beat·
US
CRDO
-4.92%
Market Beat·
US
CRDO
-4.92%

Guardant Health (GH) Valuation Check After TRICARE Coverage Win For Shield Blood Test

Guardant Health (GH) has gained attention following TRICARE's decision to cover its Shield blood test for colorectal cancer screening for military members and families in Florida. The stock has seen a 90-day return of 76.1% and a 1-year return of 189.16%. Analysts suggest a fair value of $118, indicating the stock may be undervalued at its current price of around $110. However, risks include high R&D costs and potential underwhelming payer adoption. Investors are encouraged to explore other healthcare stocks and opportunities.

Simplywall·
US
GH
+3.11%
Simplywall·
US
GH
+3.11%
© 2026 Longbridge｜Disclaimer